February 3, 2026
1 min read

India will invest $1.1B to boost development of biologics, biosimilars

Long known for manufacturing generics, vaccines and small-molecule drugs, India is attempting to shift its focus, with a big boost from its government. The country will invest 100 billion rupees ($1.1 billion) over the next five years to increase research and production of biologics and biosimilars

Leave a Reply

Your email address will not be published.

Previous Story

NASA’s Crew-12 Begins Quarantine Before February Launch to Space Station MedNews

Next Story

Baby Formula Pulled in Europe After New Safety Limits on Harmful Toxin MedNews

Previous Story

NASA’s Crew-12 Begins Quarantine Before February Launch to Space Station MedNews

Next Story

Baby Formula Pulled in Europe After New Safety Limits on Harmful Toxin MedNews

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop